A carregar...
PD-L1 and IDO1 are Expressed in Poorly-Differentiated Thyroid Carcinoma
BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have shown to be an effective treatment for a variety of carcinomas. In this study, we explore whether immune...
Na minha lista:
| Publicado no: | Endocr Pathol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6500591/ https://ncbi.nlm.nih.gov/pubmed/29372535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12022-018-9514-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|